HCAR2 Rabbit Polyclonal Antibody

HCAR2 Rabbit Polyclonal Antibody

Order Now: [email protected]

HCAR2 Rabbit Polyclonal Antibody
MBS9465276-005mL 0.05mL
EUR 300

HCAR2 Rabbit Polyclonal Antibody
MBS9465276-01mL 0.1mL
EUR 390

HCAR2 Rabbit Polyclonal Antibody
MBS9465276-5x01mL 5x0.1mL
EUR 1610

HCAR2 (Center) rabbit polyclonal antibody, Aff - Purified
AP52875PU-N 400 µl Ask for price

HCAR2 Polyclonal Antibody
ABP58759-003ml 0.03ml
EUR 189.6
Description: A polyclonal antibody for detection of HCAR2 from Human. This HCAR2 antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human HCAR2 protein at amino acid sequence of 260-340

HCAR2 Polyclonal Antibody
ABP58759-01ml 0.1ml
EUR 346.8
Description: A polyclonal antibody for detection of HCAR2 from Human. This HCAR2 antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human HCAR2 protein at amino acid sequence of 260-340

HCAR2 Polyclonal Antibody
ABP58759-02ml 0.2ml
EUR 496.8
Description: A polyclonal antibody for detection of HCAR2 from Human. This HCAR2 antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human HCAR2 protein at amino acid sequence of 260-340

HCAR2 Polyclonal Antibody
BT-AP09835-100ul 100ul Ask for price
Description: developmental stage:Expression in neutrophils occurs in the late terminal differentiation phase.,Acts as a high affinity receptor for both nicotinic acid (also known as niacin) and (D)-beta-hydroxybutyrate and mediates increased adiponectin secretion and decreased lipolysis through G(i)-protein-mediated inhibition of adenylyl cyclase. This pharmacological effect requires nicotinic acid doses that are much higher than those provided by a normal diet. Mediates nicotinic acid-induced apoptosis in mature neutrophils. Receptor activation by nicotinic acid results in reduced cAMP levels which may affect activity of cAMP-dependent protein kinase A and phosphorylation of target proteins, leading to neutrophil apoptosis.,miscellaneous:The rank order of potency for the displacement of nicotinic acid binding is 5-methyl pyrazole-3-carboxylic acid = pyridine-3-acetic acid > acifran > 5-methyl nicotinic acid = acipimox >> nicotinuric acid = nicotinamide.,Belongs to the G-protein coupled receptor 1 family.,tissue specificity:Expression largely restricted to adipose tissue and spleen. Expressed on mature neutrophils but not on immature neutrophils or eosinophils.,

HCAR2 Polyclonal Antibody
BT-AP09835-20ul 20ul Ask for price
Description: developmental stage:Expression in neutrophils occurs in the late terminal differentiation phase.,Acts as a high affinity receptor for both nicotinic acid (also known as niacin) and (D)-beta-hydroxybutyrate and mediates increased adiponectin secretion and decreased lipolysis through G(i)-protein-mediated inhibition of adenylyl cyclase. This pharmacological effect requires nicotinic acid doses that are much higher than those provided by a normal diet. Mediates nicotinic acid-induced apoptosis in mature neutrophils. Receptor activation by nicotinic acid results in reduced cAMP levels which may affect activity of cAMP-dependent protein kinase A and phosphorylation of target proteins, leading to neutrophil apoptosis.,miscellaneous:The rank order of potency for the displacement of nicotinic acid binding is 5-methyl pyrazole-3-carboxylic acid = pyridine-3-acetic acid > acifran > 5-methyl nicotinic acid = acipimox >> nicotinuric acid = nicotinamide.,Belongs to the G-protein coupled receptor 1 family.,tissue specificity:Expression largely restricted to adipose tissue and spleen. Expressed on mature neutrophils but not on immature neutrophils or eosinophils.,

HCAR2 Polyclonal Antibody
BT-AP09835-50ul 50ul Ask for price
Description: developmental stage:Expression in neutrophils occurs in the late terminal differentiation phase.,Acts as a high affinity receptor for both nicotinic acid (also known as niacin) and (D)-beta-hydroxybutyrate and mediates increased adiponectin secretion and decreased lipolysis through G(i)-protein-mediated inhibition of adenylyl cyclase. This pharmacological effect requires nicotinic acid doses that are much higher than those provided by a normal diet. Mediates nicotinic acid-induced apoptosis in mature neutrophils. Receptor activation by nicotinic acid results in reduced cAMP levels which may affect activity of cAMP-dependent protein kinase A and phosphorylation of target proteins, leading to neutrophil apoptosis.,miscellaneous:The rank order of potency for the displacement of nicotinic acid binding is 5-methyl pyrazole-3-carboxylic acid = pyridine-3-acetic acid > acifran > 5-methyl nicotinic acid = acipimox >> nicotinuric acid = nicotinamide.,Belongs to the G-protein coupled receptor 1 family.,tissue specificity:Expression largely restricted to adipose tissue and spleen. Expressed on mature neutrophils but not on immature neutrophils or eosinophils.,

HCAR2 Polyclonal Antibody
E-AB-13276-120uL 120uL
EUR 240
Description: Unconjugated

HCAR2 Polyclonal Antibody
E-AB-13276-200uL 200uL
EUR 399
Description: Unconjugated

HCAR2 Polyclonal Antibody
E-AB-13276-20uL 20uL
EUR 73
Description: Unconjugated

HCAR2 Polyclonal Antibody
E-AB-13276-60uL 60uL
EUR 143
Description: Unconjugated

HCAR2 Polyclonal Antibody
E-AB-16467-120uL 120uL
EUR 240
Description: Unconjugated

HCAR2 Polyclonal Antibody
E-AB-16467-200uL 200uL
EUR 399
Description: Unconjugated

HCAR2 Polyclonal Antibody
E-AB-16467-20uL 20uL
EUR 73
Description: Unconjugated

HCAR2 Polyclonal Antibody
E-AB-16467-60uL 60uL
EUR 143
Description: Unconjugated

HCAR2 Polyclonal Antibody
JOT-AP09835-100ul 100ul
EUR 220

HCAR2 Polyclonal Antibody
JOT-AP09835-50ul 50ul
EUR 144

HCAR2 Polyclonal Antibody
E915611 100ul
EUR 225
Description: Available in various conjugation types.

HCAR2 Polyclonal Antibody
E44H10313 100ul
EUR 255
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

HCAR2 Polyclonal Antibody
E11-202706 100ug/100ul
EUR 225
Description: Available in various conjugation types.

HCAR2 Polyclonal Antibody
MBS2517604-002mL 0.02mL
EUR 135

HCAR2 Polyclonal Antibody
MBS2517604-006mL 0.06mL
EUR 190

HCAR2 Polyclonal Antibody
MBS2517604-012mL 0.12mL
EUR 265

HCAR2 Polyclonal Antibody
MBS2517604-02mL 0.2mL
EUR 415

HCAR2 Polyclonal Antibody
MBS2517604-5x02mL 5x0.2mL
EUR 1835

HCAR2 Polyclonal Antibody
MBS2519767-002mL 0.02mL
EUR 135

HCAR2 Polyclonal Antibody
MBS2519767-006mL 0.06mL
EUR 190

HCAR2 Polyclonal Antibody
MBS2519767-012mL 0.12mL
EUR 265

HCAR2 Polyclonal Antibody
MBS2519767-02mL 0.2mL
EUR 415

HCAR2 Polyclonal Antibody
MBS2519767-5x02mL 5x0.2mL
EUR 1835

HCAR2 Polyclonal Antibody
MBS8532065-01mg 0.1mg
EUR 305

HCAR2 Polyclonal Antibody
MBS8532065-01mLAF405L 0.1mL(AF405L)
EUR 465

HCAR2 Polyclonal Antibody
MBS8532065-01mLAF405S 0.1mL(AF405S)
EUR 465

HCAR2 Polyclonal Antibody
MBS8532065-01mLAF610 0.1mL(AF610)
EUR 465

HCAR2 Polyclonal Antibody
MBS8532065-01mLAF635 0.1mL(AF635)
EUR 465

HCAR2 Polyclonal Antibody
MBS9140387-002mL 0.02mL
EUR 200

HCAR2 Polyclonal Antibody
MBS9140387-005mL 0.05mL
EUR 255

HCAR2 Polyclonal Antibody
MBS9140387-01mL 0.1mL
EUR 345

HCAR2 Rabbit Polyclonal Antibody